The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
Department of Radiation Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
World J Surg Oncol. 2024 Aug 6;22(1):210. doi: 10.1186/s12957-024-03485-4.
Breast cancer is a common malignancy, and early detection coupled with standardized treatment is crucial for patient survival and recovery. This study aims to scrutinize the current state of breast cancer diagnosis and treatment in Shaanxi province, providing valuable insights into the local practices and outcomes.
We selected 25 hospitals that typically represent the current diagnosis and treatment strategy of breast cancer in Shaanxi (a province in northwest China). The questionnaire comprised sections on fundamental information, outpatient consultations, breast-conserving surgery, neoadjuvant and adjuvant therapy, sentinel lymph node biopsy, breast reconstruction surgery.
A total of 6665 breast cancer operations were performed in these 25 hospitals in 2021. The overall proportion of breast-conserving surgery (BCS) is 23.6%. There was a statistically significant positive correlation between the annual volume of breast cancer surgery and the implementation rate of BCS (P = 0.004). A total of 2882 cases of neoadjuvant treatment accounted for 43.24% of breast cancer patients treated with surgery in 2017. Hospitals in Xi'an performed more neoadjuvant therapy for patients with breast cancer compared to other districts (P = 0.008). There was a significantly positive correlation between outpatient visits and the implementation rate of sentinel lymph node biopsy (SLNB) (P = 0.005). 14 hospitals in Shaanxi performed reconstructive surgery.
Breast conserving surgery, adjuvant and neoadjuvant therapy and sentinel lymph node biopsy in Shaanxi province have reached the China's average level. Moreover, hospitals in Xi 'an have surpassed this average. However, a disparity is observed in the development of breast reconstruction surgery when compared to top-tier hospitals.
乳腺癌是一种常见的恶性肿瘤，早期发现并规范化治疗对患者的生存和康复至关重要。本研究旨在审视陕西省乳腺癌的诊断和治疗现状，为了解当地的实践和结果提供有价值的见解。
我们选择了 25 家医院，这些医院通常代表了陕西省乳腺癌的当前诊断和治疗策略（中国西北部的一个省份）。问卷包括基本信息、门诊咨询、保乳手术、新辅助和辅助治疗、前哨淋巴结活检、乳房重建手术等部分。
2021 年，这 25 家医院共进行了 6665 例乳腺癌手术。保乳手术（BCS）的总体比例为 23.6%。乳腺癌手术年量与 BCS 实施率之间呈显著正相关（P=0.004）。2017 年，接受手术治疗的乳腺癌患者中，共有 2882 例接受新辅助治疗，占 43.24%。与其他地区相比，西安市的医院为乳腺癌患者进行了更多的新辅助治疗（P=0.008）。门诊就诊次数与前哨淋巴结活检（SLNB）的实施率呈显著正相关（P=0.005）。陕西省有 14 家医院开展了重建手术。
陕西省的保乳手术、辅助和新辅助治疗以及前哨淋巴结活检已达到中国平均水平。此外，西安市的医院已经超过了这一平均水平。然而，与顶级医院相比，乳房重建手术的发展存在差距。
